CClinicalTrials.gg
CompletedNCT05789992eMACUpdated Jun 15, 2023

Evaluation of Equivalent Minimum Alveolar Concentration (eMAC) During Propofol/Remifentanil Anesthesia

An interventional study of Propofol and Low Remifentanil in General Anaesthesia, sponsored by Zhang Haopeng. Completed at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-06-15.

Sponsored by Zhang Haopeng · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study is to verify the accuracy of eMAC compared to Bispectral Index (BIS) for depth and nociceptive stimulation monitoring of anesthesia during general anesthesia.

Read the detailed description

eMAC is a new index based on response surface model for evaluating anesthesia state and anti-nociceptive stimulation levels. To valid it's clinical accuracy, a protocol was designed.

Patients will be allocated to receive a specific effect-site concentration of remifentanil and propofol during tonic electrical stimulation (5s, 50mA) and intubation. The concentration combinations include the electrical stimulation combination (effector chamber concentration random: remifentanil 0-3 ng/ml, propofol 3-5 ug/ml) and the intubation combination (effector chamber concentration random: remifentanil 3-5 ng/ml, propofol 3-5 ug/ml). All combinations were decided before operation. Every combination had a 5 min equilibration period, and the vital signs (Heart Rate, Blood pressure, any body movement) and BIS, eMAC will be recorded before and after the electrical stimulation and intubation. After this period, patients will be randomly allocated to receive an intravenous anesthesia or intravenous combined anesthesia, and regular anesthesia is executed. This study only records vital signs and BIS, eMAC during maintenance period of perioperative.

02

Conditions studied

  • General Anaesthesia
03

In context

Lead sponsor

This is the only study on the registry with Zhang Haopeng as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Patients undergoing elective surgery under general anesthesia;
  2. Patients with ASA rating I\~III;
  3. The age of the patient is more than 18 years old;
  4. The informed consent has been signed;

Exclusion criteria

Exclusion Criteria:

  1. Patients who are participating in other trials;
  2. Patients with cognitive impairment, mental illness or taking psychotropic drugs within three months;
  3. Patients with a history of stroke;
  4. Patients with a history of alcoholism (long-term drinking more than 5 years, daily white wine consumption ≥ 50ml);
  5. Pregnant women;
  6. Patients with BMI>30;
  7. Patients and family members who are unwilling to participate after understanding the research content;
  8. According to the evaluation of the researcher, the actual condition is not suitable for the patients participating in this trial.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
62 participants (actual)

Study arms

  • Active comparator
    Group 1 BIS under tetanic electrical stimulation

    During tetanic electrical stimulation, and with propofol(random:3-5ug/ml) and remifentanil(random:0-3ng/ml), the response (body movement or hemodynamic change) was observed, and recorded it's BIS.

    Drug: Propofol · Drug: Low Remifentanil · Procedure: tetanic electrical stimulation

  • Active comparator
    Group 2 eMAC under tetanic electrical stimulation

    During tetanic electrical stimulation or intubation, and with propofol(random:3-5ug/ml) and remifentanil(random:0-3ng/ml), the response (body movement or hemodynamic change) was observed, and recorded it's eMAC.

    Drug: Propofol · Drug: Low Remifentanil · Procedure: tetanic electrical stimulation

  • Active comparator
    Group 3 BIS under intubation

    During intubation, and with propofol(random:3-5ug/ml) and remifentanil(random:3-5ng/ml), the response (body movement or hemodynamic change) was observed, and recorded it's BIS.

    Drug: Propofol · Drug: Heigh Remifentanil · Procedure: Intubation

  • Active comparator
    Group 4 eMAC under intubation

    During intubation, and with propofol(random:3-5ug/ml) and remifentanil(random:3-5ng/ml), the response (body movement or hemodynamic change) was observed, and recorded it's eMAC.

    Drug: Propofol · Drug: Heigh Remifentanil · Procedure: Intubation

Interventions

  • DrugPropofol

    Propofol (Random:3-5ug/ml)

    Also known as: Propofol for tetanic electrical stimulation and intubation

  • DrugLow Remifentanil

    Remifentanil (Random:0-3ug/ml)

    Also known as: Remifentanil for tetanic electrical stimulation

  • DrugHeigh Remifentanil

    Remifentanil (Random:3-5ug/ml)

    Also known as: Remifentanil for intubation

  • ProcedureIntubation

    Endotracheal intubation before surgery

  • Proceduretetanic electrical stimulation

    tetanic electrical stimulation before surgery

06

What researchers measure

Primary outcomes

  1. Prediction probability of eMAC

    Prediction probability is an index(range:0-1) to describe the concordance between continuous measures and discrete scores. Prediction probability bettween eMAC and the lable of response was calculated.

    Time frame: 1 year

Secondary outcomes

  1. Prediction probability of BIS

    Prediction probability is an index(range:0-1) to describe the concordance between continuous measures and discrete scores. Prediction probability bettween BIS and the lable of response was calculated.

    Time frame: 1 year

07

Study locations

1 site
  • Xijing Hospital
    Xian, Shaanxi, China
08

References and documents

Publications

  • Luginbuhl M, Schumacher PM, Vuilleumier P, Vereecke H, Heyse B, Bouillon TW, Struys MM. Noxious stimulation response index: a novel anesthetic state index based on hypnotic-opioid interaction. Anesthesiology. 2010 Apr;112(4):872-80. doi: 10.1097/ALN.0b013e3181d40368. PubMed 20216387 ↗
  • Gruenewald M, Ilies C, Herz J, Schoenherr T, Fudickar A, Hocker J, Bein B. Influence of nociceptive stimulation on analgesia nociception index (ANI) during propofol-remifentanil anaesthesia. Br J Anaesth. 2013 Jun;110(6):1024-30. doi: 10.1093/bja/aet019. Epub 2013 Mar 6. PubMed 23471754 ↗
  • Schumacher PM, Dossche J, Mortier EP, Luginbuehl M, Bouillon TW, Struys MM. Response surface modeling of the interaction between propofol and sevoflurane. Anesthesiology. 2009 Oct;111(4):790-804. doi: 10.1097/ALN.0b013e3181b799ef. PubMed 19741484 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 15, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05789992
Lead sponsor
Zhang Haopeng
Responsible party
Zhang Haopeng (Associate professor, Xijing Hospital) — Sponsor-investigator
First posted
Mar 29, 2023
Start date
Apr 3, 2023
Primary completion
Apr 29, 2023
Completion
Apr 29, 2023
Last update
Jun 15, 2023

Study contacts

Haopeng Zhang, Dr
principal investigator · Xijing Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion